QCM Cayman, Ltd.

SEC CIK: 0001166340
Latest filing: Nov 4, 2024

SEC filings (opens in a new tab)

ABUS holding history

Arbutus Biopharma Corp in every 13F filed by QCM Cayman, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABUS overview All 13F holders of ABUS Full Q3 2024 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of ABUS by QCM Cayman, Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−10,205−100.0%	Sold out	Holders
Q4 2021	10,205	$40.0K	0.2%	+10,205	New	Holders
Q2 2021	0	$0	0.0%	−12,728−100.0%	Sold out	Holders
Q1 2021	12,728	$42.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.